Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RZLT
#2756
Rezolute, Inc. Common Stock (NV)
3.2
1
-1.53%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.53%
Monthly Change
-8.29%
6 month change
-55.72%
Year Change
-24.47%
Previous Close
3.2
6
Open
3.2
1
Bid
Ask
Low
3.2
1
High
3.2
1
Volume
66
Markets
US Stock Market
Healthcare
RZLT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
TTM
Key stats
Total common shares outstanding
85.52 M
90.81 M
92.73 M
95.7 M
—
Valuation ratios
Enterprise value
233.41 M
310.91 M
862.54 M
213.95 M
1.62 B
Price to earnings ratio
6.61
-4.55
17.64
62.92
82.62
Price to sales ratio
74.42
—
16.78 K
7 456.56
—
Price to cash flow ratio
2.44
4.91
9.19
2.35
18.88
Price to book ratio
0.38
2.09
1.35
0.36
4.19
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.2
0.14
0.11
0.16
0.62
Return on equity %
0.23
0.15
0.12
0.18
0.68
Return on invested capital %
—
-618.92
—
—
—
Gross margin %
100
—
100
—
—
Operating margin %
333.72 K
—
132.11 K
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
314.87 K
—
121.33 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
8.43
14.37
15.15
14.18
52.13
Inventory turnover
—
—
—
—
—
Asset turnover
0
—
0
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.29
0.29
0.19
0.22
0.99
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
1.44
2.21
1.7
1.42
6.77
Net current asset value per share
1.47
2.25
1.73
1.45
6.89
Tangible book value per share
1.18
2.13
1.42
1.23
5.97
Working capital per share
1.29
2.1
1.61
1.35
6.34
Book value per share
1.36
2.13
1.64
1.37
6.51
News
Alger Small Cap Growth Fund Q4 2025 Portfolio Update
Jefferies reiterates Buy rating on Rezolute stock, maintains $4 target
Rezolute shares mixed results from Phase 3 trial for rare disease therapy
Leerink Partners reiterates Outperform rating on XOMA stock at $45 target
RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know
Rezolute CFO Evans buys shares worth $79,577
Elam Nevan C, Rezolute CEO, buys $50k in RZLT shares
Rezolute’s CCO Karnawat buys $19,598 in shares
Down 81.8% in 4 Weeks, Here's Why Rezolute (RZLT) Looks Ripe for a Turnaround
Micron, Nike Set To Report Earnings Next Week
Craig-Hallum downgrades Rezolute stock to Hold on failed Phase III trial
XOMA stock maintains Buy rating at Benchmark despite partner’s trial setback